Paula Robinson, MD
Family Medicine · Louisville, KYNPI 1437231230
Payments from drug & device makers
Across 19 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$100
- Astellas Pharma US Inc$72
- Alkermes, Inc.$51
- Vanda Pharmaceuticals Inc.$32
- Boston Scientific$30
- Soleno Therapeutics, Inc.$24
- plus $64 from 4 others
What the payments were for
- Food & beverage$373100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 6 | $100 |
| Astellas Pharma US Inc | 4 | $72 |
| Alkermes, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Boston Scientific | 1 | $30 |
| Soleno Therapeutics, Inc. | 1 | $24 |
| Indivior Inc. | 1 | $18 |
| Livanova USA, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$373 in reported general payments places this provider in the 35th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 45 | $25,483 |
| JardianceEmpagliflozin | 15 | $9,017 |
| EliquisApixaban | 12 | $7,245 |
| Aripiprazole | 31 | $5,562 |
| Levocarnitine | 27 | $5,004 |
| Famotidine | 380 | $4,163 |
| Rosuvastatin Calcium | 117 | $2,245 |
| Lactulose | 48 | $1,878 |
| Levothyroxine Sodium | 175 | $1,735 |
| Omeprazole | 79 | $1,561 |
| Fluticasone Propionate | 71 | $1,469 |
| Haloperidol | 12 | $1,144 |
| Potassium Chloride | 39 | $1,076 |
| Pantoprazole Sodium | 43 | $998 |
| Bumetanide | 12 | $967 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Louisville
- Christopher RhyneLouisville$1M
- Michael LovelaceLouisville$244K
- Suraj GathaniLouisville$69K
- Mandy WhittLouisville$38K
- Michael PendletonLouisville$29K
- Rajanbhai AminLouisville$26K
- James WrightLouisville$18K
- Rosenberg ReyesLouisville$18K
- Dennis GrayLouisville$14K
- Vincent LangLouisville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.